News
-
-
-
-
-
-
PRESS RELEASE
Issuance of New European Patent Bolsters IP Protection for Jaguar Health in the Treatment of Congenital Diarrheal Disorders (CDDs)
New patent issued for core rare disease target indication for crofelemer. European Patent Office grants Napo Pharmaceuticals patent to use crofelemer for congenital diarrheal disorders (CDDs). Jaguar supports studies in SBS and MVID, with results by 2025 -
PRESS RELEASE
National Security Expert Egon Cholakian Breaks Protocol to Speak About Concerning Findings in Recent Documentary 'The Impact'
Dr. A. Egon Cholakian, national security expert & lobbyist, presents analysis of geopolitical tensions & climate crisis. Discussed puzzle coding, escalating disasters in Russia & warnings to Putin -
-
-
